However, there have only been a few studies to explore this approach for neural diseases [133], and the effects of HGF have often been perceived as integral components within the complete secretome of MSCs, working in concert with other cytokines to contribute to the overall exerted neuroprotective functions for PD therapy [301]. The gene discussed is HGF; the disease is Parkinson disease.